- Home
- COCH
COCH
Envoy Medical Inc.
as of 12-12-2025 4:00pm EST
$0.81
$0.03
-3.27%
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Chart Type:
Time Range:
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WHITE BEAR LAKE |
| Market Cap: | 24.4M | IPO Year: | N/A |
| Target Price: | $9.50 | AVG Volume (30 days): | 448.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.64 - $2.25 | Next Earning Date: | 11-10-2025 |
| Revenue: | $208,000 | Revenue Growth: | -25.18% |
| Revenue Growth (this year): | -12.51% | Revenue Growth (next year): | 29.53% |
AI-Powered COCH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 67.86%
67.86%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Envoy Medical Inc. News
COCH Breaking Stock News: Dive into COCH Ticker-Specific Updates for Smart Investing
Simply Wall St.
Positive Signs As Multiple Insiders Buy Envoy Medical Stock
📊
AI Sentiment
Positive
7/10
Compare COCH vs Leading Stocks
See how COCH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "COCH Envoy Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.